Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calvin Law

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 4, 2015
Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional AnalysisDanielle A Bischof, Rebecca Dodson, M Carolina Jimenez, et al.
Iscience|November 24, 2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cellsAbdul S Qadir, Jean Philippe Guégan, Christophe Ginestier, et al.
Annals of Surgical Oncology|April 26, 2014
Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomesDanielle A Bischof, Yuhree Kim, Rebecca Dodson, et al.
JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.
Endocrine-Related Cancer|February 26, 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo modelNilakshi Kulathunga, Rusha Chakraborty, Yan Li, et al.
Annals of Surgery|March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panelNatalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery|October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panelMatthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Journal of the American College of Surgeons|May 14, 2013
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness studySavtaj Brar, Calvin Law, Robin McLeod, et al.
Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Cell Reports|March 9, 2017
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon ResponseAbdul S Qadir, Paolo Ceppi, Sonia Brockway, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 4, 2015
Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional AnalysisDanielle A Bischof, Rebecca Dodson, M Carolina Jimenez, et al.
Iscience|November 24, 2021
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cellsAbdul S Qadir, Jean Philippe Guégan, Christophe Ginestier, et al.
Annals of Surgical Oncology|April 26, 2014
Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomesDanielle A Bischof, Yuhree Kim, Rebecca Dodson, et al.
JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.
Endocrine-Related Cancer|February 26, 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo modelNilakshi Kulathunga, Rusha Chakraborty, Yan Li, et al.
Annals of Surgery|March 13, 2013
Optimal management of gastric cancer: results from an international RAND/UCLA expert panelNatalie Coburn, Rajini Seevaratnam, Lawrence Paszat, et al.
Surgery|October 1, 2013
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panelMatthew Dixon, Alyson Mahar, Lawrence Paszat, et al.
Journal of the American College of Surgeons|May 14, 2013
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness studySavtaj Brar, Calvin Law, Robin McLeod, et al.
Annals of Surgical Oncology|September 4, 2012
A RAND/UCLA appropriateness study of the management of familial gastric cancerMatthew Dixon, Rajini Seevaratnam, Debrah Wirtzfeld, et al.
Pageof 12